Discovery Ventures

Discovery Ventures provides strategic capital and operational expertise to emerging healthcare companies. The firm specializes in identifying and nurturing early to growth-stage biotech and medtech ventures. Leveraging partners' extensive scientific, medical, and entrepreneurial backgrounds, it focuses on innovative therapies and technologies addressing unmet medical needs.

Built on over fifteen years of venture capital history, Discovery Ventures emerged from a collective insight into life sciences' transformative potential. Key partners like Guillen Lopez, Serge Picaud, and Andrea Spezzi bring diverse backgrounds in biomedical engineering, neuroscience, and pharmaceutical development. Their combined experience in R&D, company formation, and commercialization underpins the firm's operational guidance and investment philosophy.

The firm's clientele consists of visionary entrepreneurs and innovative startups disrupting the biotech and medtech landscapes. Discovery Ventures supports these companies in translating scientific breakthroughs into tangible healthcare solutions. Its overarching vision is to accelerate pioneering medical advancements, contributing to a future where diseases are cured, prevented, or managed, improving global health outcomes.